Regeneron Pharmaceuticals shares owned by Boston Common Asset Management
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Boston Common Asset Management
from 13F filings
Historical chart of Boston Common Asset Management investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Boston Common Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Boston Common Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $33M | 34k | 962.48 |
| 2023-12-31 | $38M | 43k | 878.29 |
| 2023-09-30 | $37M | 44k | 822.96 |
| 2023-06-30 | $35M | 49k | 718.53 |
| 2023-03-31 | $42M | 51k | 821.68 |
| 2022-12-31 | $39M | 54k | 721.49 |
| 2022-09-30 | $37M | 54k | 688.87 |
| 2022-06-30 | $35M | 59k | 591.13 |
| 2022-03-31 | $30M | 43k | 698.42 |
| 2021-12-31 | $27M | 42k | 631.51 |
| 2021-09-30 | $25M | 42k | 605.17 |
| 2021-06-30 | $23M | 42k | 558.54 |
| 2021-03-31 | $12M | 25k | 473.13 |
| 2020-12-31 | $5.6M | 12k | 483.07 |
| 2020-09-30 | $6.2M | 11k | 559.81 |
| 2020-06-30 | $7.0M | 11k | 623.68 |
| 2020-03-31 | $5.6M | 11k | 488.32 |
| 2019-12-31 | $6.0M | 16k | 375.47 |
| 2019-09-30 | $4.6M | 17k | 277.42 |
| 2019-06-30 | $5.4M | 17k | 313.02 |
| 2019-03-31 | $5.3M | 13k | 410.59 |
| 2018-12-31 | $4.9M | 13k | 373.49 |
| 2018-09-30 | $4.2M | 10k | 404.05 |
| 2018-06-30 | $4.0M | 12k | 344.99 |
| 2018-03-31 | $4.1M | 12k | 344.33 |
| 2017-12-31 | $4.5M | 12k | 376.00 |
| 2017-09-30 | $5.2M | 12k | 447.13 |
| 2017-06-30 | $5.7M | 12k | 491.17 |
| 2017-03-31 | $5.8M | 15k | 387.51 |
| 2016-12-31 | $4.3M | 12k | 367.07 |
| 2016-09-30 | $4.7M | 12k | 402.00 |
| 2016-06-30 | $3.2M | 9.2k | 349.20 |
| 2016-03-31 | $1.7M | 4.8k | 360.48 |
More positions owned by Boston Common Asset Management
View all positions for Boston Common Asset Management